ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2015 American Transplant Congress

    Umbilical Vein Catheter Versus Double J Stent for Ureteric Anastomosis in Renal Transplantation: A Single Centre, Open Label, Randomized Trial

    V. Swaroop, A. Pereira, S. Smith, O. Masood, R. Pararajasingam, T. Augustine, H. Riad, S. Mehra, A. Tavakoli.

    Transplant Surgery, Manchester Royal Infirmary, Manchester, United Kingdom.

    Introduction: Double J (DJ) stents are used routinely in renal transplantation to prevent ureteric complications. A recent Cochrane review of literature showed that routine prophylactic…
  • 2015 American Transplant Congress

    Propensity Score-Weighted Analysis of Induction Therapies in Live Donor Kidney Transplantation in Modern Immunosuppression Era

    B. Tanriover,1 S. Zhang,2 M. MacConmara.3

    1Medicine, UTSW, Dallas, TX; 2Clinical Sciences, UTSW, Dallas, TX; 3Surgery, UTSW, Dallas, TX.

    Background: Induction therapy with interleukin-2 receptor antagonist (IL2-RA) is recommended as a first line agent in living donor renal transplantation (LRT). However, use of IL2-RA…
  • 2015 American Transplant Congress

    Final Results from the BENEFIT-EXT Trial: A 7 Year Follow-Up of Belatacept Treated Patients

    S. Florman,1 J. Medina Pestana,2 M. Rial,3 L. Rostaing,4 D. Kuypers,5 F. Mühlbacher,6 M. Polinsky,7 U. Meier-Kriesche,7 J. Grinyó,8 A. Durrbach.9

    1Mt Sinai Med Ctr, NY; 2Hosp do Rim e Hipertensão, Sao Paulo, Brazil; 3Inst de Nefrologia, Buenos Aires, Argentina; 4Univ Hospital, Toulouse, France; 5Univ Hospital Leuven, Leuven, Belgium; 6Vienna Transplantation Ctr, Vienna, Austria; 7BMS, Lawrenceville; 8Univ Hosp Bellvitge, Barcelona, Spain; 9Univ Hosp of Bicêtre, Villejuif, France.

    Background: At 3 and 5yrs post-transplant, BENEFIT-EXT showed a renal function benefit and consistent safety in belatacept (bela) treated pts vs cyclosporine (CsA). Final 7…
  • 2015 American Transplant Congress

    The C1q-Binding Assays and Clinical Outcomes in Kidney Transplantation

    P. Amico,1 G. Hönger,1 H. Hopfer,2 R. Liwski.3

    1Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland; 2Institute for Pathology, University Hospital Basel, Basel, Switzerland; 3Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, Canada.

    Background: Contradictory conclusions have emerged from clinical trials when testing the predictive value of C1q-binding donor-specific HLA-antibodies (HLA-DSA). The aim of this study was to…
  • 2015 American Transplant Congress

    Donor and Recipient Pretransplant Polyoma BK Serostatus: Relationship to BK-Viremia After Renal Transplantation

    H. Tseng, R. Lopez-Soler, N. Chandolias, T. Friedrich, J. Eldor, D. Conti.

    Surgery, Albany Medical College, Albany, NY.

    Background:Polyoma virus BK nephropathy is a serious complication after renal transplantation and is associated with a significant risk of graft loss and dysfunction. This study…
  • 2015 American Transplant Congress

    Patients With Severe and Morbid Obesity Benefit from Deceased Donor Kidney Transplant

    A. Nishio Lucar,1 J. Ma,2 G. Vranic,1 D. Keith.1

    1Medicine, University of Virginia, Charlottesville, VA; 2Biostatistics, University of Virginia, Charlottesville, VA.

    More than one in three Americans are obese yet obesity is considered a relative and sometimes absolute contraindication to kidney transplant. Previous studies suggest that…
  • 2015 American Transplant Congress

    Resolution of Glomerular Fibrin Thrombi in Deceased Donor Kidneys

    R. Batra,1 M. Smith,3 L. Thomas,2 H. Khamash,2 A. Moss,2 J. Huskey,2 A. Singer,1 A. Mathur,1 N. Katariya,1 K. Reddy,1 R. Heilman.2

    1Transplant Surgery, Mayo Clinic, Phoenix, AZ; 2Transplant Nephrology, Mayo Clinic, Phoenix, AZ; 3Pathology, Mayo Clinic, Phoenix, AZ.

    BackgroundDeceased donor kidneys with Glomerular Fibrin Thrombi (GFT) are frequently discarded, but these kidneys may offer an opportunity to increase deceased donor organs. Our aim…
  • 2015 American Transplant Congress

    Eculizumab in Prevention of Acute Antibody-Mediated Rejection in Sensitized Deceased-Donor Kidney Transplant Recipients: 1-Year Outcomes

    D. Glotz,1 G. Russ,2 L. Rostaing,3 C. Legendre,4 S. Chadban,5 J. Grinyo,6 N. Mamode,7 E. Cozzi,11 Y. Lebranchu,8 S. Sandrini,9 L. Couzi,12 W. Marks.10

    1H St-Louis, Paris, France; 2Ryl Adelaide H, Adelaide, Australia; 3CHU Rangueil, Toulouse, France; 4H Necker, Paris, France; 5Ryl Pr Alfred H, Camperdown, Australia; 6H U deBellvitge, Barcelona, Spain; 7Guy's H, London, United Kingdom; 8H Bretonneau CHU, Tours, France; 9Spedali Cvl di Brescia, Brescia, Italy; 10Alexion, Cheshire; 11Via Giustiniani, Padua, Italy; 12Hopital Pellegrin, CHU Bordeaux, Bordeaux, France.

    Complement activation by preformed DSA is a major mechanism of acute antibody-mediated rejection (aAMR) in sensitized kidney transplant recipients (KTR). We previously reported interim study…
  • 2015 American Transplant Congress

    Prediction of Delayed Graft Function By Means of a Web-Based Calculator in Living Related Kidney Transplant: Mexican Single Center Experience

    G. Martinez-Mier,1 E. Soto-Miranda,1 M. Mendez Lopez,1 L. Budar Fernandez,1 M. Trujillo-Martinez,2 A. Uscanga-Montesano,2 D. Avila y Falfan.2

    1Organ Transplantation, IMSS UMAE189/HRAEV Nefrologia y Trasplantes de Veracruz, Veracruz, Mexico; 2Research, IMSS UMAE 189, Veracruz, Mexico.

    Background: Delayed graft function (DGF) is associated with, poor graft survival. Irish validated a model to predict DGF for deceased donor transplants. The model was…
  • 2015 American Transplant Congress

    Incorporating Markers of Donor Organ Intrinsic Biology Into Donor Quality Evaluation

    J. Suh, K. Archer, L. Gallon, I. McConell, A. King, D. Maluf, V. Mas.

    UVA, Charlottesville, VA; Northwestern University, Chicago, IL; VCU, Richmond, VA.

    Background. We aimed to identify a reliable composite scoring system (clinical / biological) to evalute organ quality and predict outcomes post-kidney transplantation (KT).Methods. 233 deceased…
  • « Previous Page
  • 1
  • …
  • 507
  • 508
  • 509
  • 510
  • 511
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences